Clinical Trials in China / NCT07311655
Starting soon
Observational
Validation of the Accuracy of an AI-Based System for Diagnosing Anxiety Disorders
NCT07311655 · tracked via the Priya Life Science China tracker
Condition(s) studied
Anxiety Disorders
Study summary
The trial aimed to evaluate the efficacy of an artificial intelligence-based system for diagnosing anxiety disorders. Specifically, it sought to determine whether the system's assessment validity is non-inferior to that of psychiatric specialists.
Eligibility
1. Subjects with anxiety disorders
* Inclusion Criteria:
* In accordance with ICD-11 for Anxiety Disorders;
* Between the ages of 18-60;
* Ability to use computers or smartphone;
* Native Chinese speaker;
* Signing informed consent.
* Exclusion Criteria:
* With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;
* With a high risk of suicide or self-injury;
* With severe physical diseases, central nervous system diseases, or substance abuse;
* With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
2. Health Control
* Inclusion Criteria:
* Not meet ICD-11 criteria for Mental Disorders;
* Between the ages of 18-60;
* Ability to use computers or smartphone;
* Native Chinese speaker;
* Signing informed consent.
* Exclusion Criteria:
* With mental illness, or unable to complete the required assessment and treatment;
* With severe physical diseases, central nervous system diseases, or substance abuse;
* With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
3. Psychiatrist
* Inclusion Criteria:
* Over 18 years old;
* A minimum of three years' experience in anxiety and other mental health fields;
* Intermediate or higher professional title;
* Currently employed in the selected test region;
* Signing informed consent.
Primary outcome measure(s)
- Diagnostic Accuracy (Sensitivity, Specificity, and Area Under the Curve) of the AI-Based Screening System for Anxiety Disorders — through study completion, an average of 1 week
In this study, the evaluation results of the subjects were taken as the gold standard based on the diagnostic conclusions of psychiatrists. The screening results of the aided-diagnostic system were compared with the diagnostic conclusions of the psychiatrists to verify the screening effectiveness of this system. Sensitivity : Calculated as \[True Positives / (True Positives + False Negatives)\], evaluating the AI system's ability to correctly identify patients with anxiety. Specificity : Calculated as \[True Negatives / (True Negatives + False Positives)\], evaluating the AI system's ability to correctly exclude non-anxious individuals.Area Under the Receiver Operating Characteristic Curve (AUC), which comprehensively evaluates the diagnostic discriminative power of the system by plotting sensitivity versus 1-specificity across different decision thresholds and calculating the AUC value .
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Shanghai Mental Health Center | Shanghai | Shanghai Municipality |
More Shanghai Mental Health Center trials in China
Other trials for the same condition
Effects of tDCS on Fear Reversal in Patients With Anxiety Disorders
Enrolling by invitation
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07311655 on ClinicalTrials.gov ↗ ← All trials in China